BTG Share News (BTG)
BTG Share
BTG Share
BTG Share
BTG Share
BTG
BTG Share
BTG Broker
BTG Directors
BTG Financial
BTG
BTG Short
BTGWed, 27th May 2015 07:57
(ShareCast News) - RBC Capital Markets initiated coverage of specialist pharmaceutical company BTG at 'outperform' with a price target of 820p, saying it should be a long-term holding. It said the shares have underperformed materially over the past year and, while medium-term market expectations are
Read more(ShareCast News) - Specialist pharmaceutical firm BTG said it had won US regulatory approval for its LC Bead Lumi radiation treatment. The company added that a trial of its PneumRx endobronchial coil implant for severe emphysema had produced positive results with all primary and secondary endpoints
Read more
(ShareCast News) - Healthcare group BTG has posted an increase in interim pre-tax profit, boosted by solid growth across all of its divisions. In the six months to 30 September, the FTSE 250 group posted a 40.6% year-on-year increase in pre-tax profit to £52.9m, while revenue rose 20% to £229.6m. T
Read more(ShareCast News) - After an initial stumble, the FTSE 250 fought its way back into positive territory over the day, By 1420 GMT, the UK mid-cap index was up 0.28% at just over 17,000 points, but not rising as fast as its blue chip sister index 0.85% gain. Pharmaceutical group BTG was given a shot i
Read more(ShareCast News) - London's FTSE 250 index was down 0.2% at 17,101.89 just after 1400 BST, underperforming the broader market. Miners were firmly on the front foot as metals prices advanced and the sector got a boost from an upbeat note by Morgan Stanley. The bank upgraded its stance on the European
Read more